How it works Convidencia is a viral vector vaccine using adenovirus five. With a viral vector, there is essentially a viral particle, which is programmed not to replicate. So, what is administered ...

Viral vector vaccines use a version of a mild virus to safely deliver ... the ‘spike’ protein. This type of vaccine makes your immune system familiar with the spike protein, so it can kill the ...

Triplex is a universal recombinant Modified Vaccinia Ankara viral vector vaccine. "Fortress doses first subject in Phase II CMV vaccine trial" was originally created and published by Clinical ...

Announcing a new article publication for Zoonoses journal. Vaccinia virus (VACV) confers cross-protective immunity against the variola virus, the causative agent of smallpox, and has therefore been ...

Department of Health and Human Services Secretary Robert F. Kennedy Jr. paused a $240 million contract to create a new coronavirus vaccine.

The global viral vector and plasmid DNA manufacturing market size is calculated at USD 8.66 billion in 2025 and is expected ...

The research exploded online, and as STAT’s Helen Branswell writes, became a parable for the ways in which the internet is being used to weaponize basic vaccine research vital to advancing ...

Results of IMNN-101 Proof-of-Concept study demonstrate persistent immunogenicity in trial participants and further validate PlaCCine® ...

As the industry moves towards a more integrated and diversified vaccine ecosystem, GeoVax’s MVA-based vaccines should provide a scalable, durable, and globally accessible solution that enhances the ...

IAVI said its Ebola Sudan vaccine candidate uses the same viral vector platform as Merck's single-dose Zaire Ebola virus vaccine. "Overall, it's a very similar vaccine, adapted for Sudan ...